- Home
- CNOBP vs KRMD Comparison
CNOBP vs KRMD Comparison
Compare CNOBP & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNOBP | KRMD |
|---|---|---|
| Founded | N/A | 1980 |
| Country | United States | United States |
| Employees | 756 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 189.3M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CNOBP | KRMD |
|---|---|---|
| Price | $24.97 | $3.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $6.50 |
| AVG Volume (30 Days) | 4.0K | ★ 120.4K |
| Earning Date | N/A | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.85 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $41,127,366.00 |
| Revenue This Year | N/A | $20.32 |
| Revenue Next Year | N/A | $17.37 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 22.23 |
| 52 Week Low | $22.35 | $2.63 |
| 52 Week High | $25.12 | $6.61 |
Technical Indicators
Market Signals| Indicator | CNOBP | KRMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.23 | 43.56 |
| Support Level | $24.54 | $3.88 |
| Resistance Level | $24.83 | $4.34 |
| Average True Range (ATR) | 0.08 | 0.18 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 2.35 | 13.64 |
Price Performance
Historical ComparisonAbout CNOBP ConnectOne Bancorp Inc.
ConnectOne Bancorp Inc is a community-based, full-service New Jersey-chartered commercial bank. Substantially all loans are secured with various types of collateral, including business assets, consumer assets, and commercial/residential real estate. Each borrower's ability to repay its loans is dependent on the conversion of assets, cash flows generated from the borrowers' business, real estate rental, and consumer wages.
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.